Elyse G. Seltzer
Corporate Officer/Principal chez Yale University
Postes actifs de Elyse G. Seltzer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Yale University | Corporate Officer/Principal | - | - |
Historique de carrière de Elyse G. Seltzer
Anciens postes connus de Elyse G. Seltzer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| UROGEN PHARMA LTD. | Directeur Technique/Scientifique/R&D | 12/12/2017 | 01/04/2020 |
| Corporate Officer/Principal | 01/04/2020 | 01/05/2023 | |
| NABRIVA THERAPEUTICS PLC | Directeur Technique/Scientifique/R&D | 23/06/2017 | 30/09/2017 |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Directeur Technique/Scientifique/R&D | 04/05/2015 | 01/09/2017 |
| GSK PLC | Corporate Officer/Principal | 01/09/2009 | 01/04/2015 |
| TENGION, INC. | Directeur Technique/Scientifique/R&D | 01/11/2006 | 01/08/2009 |
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Corporate Officer/Principal | - | - |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - | - |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Corporate Officer/Principal | - | - |
Formation de Elyse G. Seltzer
| University of Pennsylvania | Undergraduate Degree |
| New York University School of Medicine | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 9 |
| Royaume-Uni | 2 |
| Autriche | 2 |
Opérationnelle
| Corporate Officer/Principal | 6 |
| Chief Tech/Sci/R&D Officer | 4 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 9 |
| Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| TENGION, INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| GSK PLC | Health Technology |
| NABRIVA THERAPEUTICS PLC | Health Technology |
| UROGEN PHARMA LTD. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Health Technology |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Health Technology |
- Bourse
- Insiders
- Elyse G. Seltzer
- Expérience
